Characterization of genetic changes in MCL by interphase FISH on tissue sections

References

• Remstein E D, Kurtin P J, Buno I, Bailey R J, Proffitt J, Wyatt W A, et al. Diagnostic utility of fluorescence in situ hybridization in mantle-cell lymphoma. Br J Haematol 2000; 110: 856–862
   PubMed Web of Science ®Google Scholar
• Belaud-Rotureau M A, Parrens M, Dubus P, Garroste J C, de Mascarel A, Merlio J P. A comparative analysis of FISH, RT-PCR, PCR, and immunohistochemistry for the diagnosis of mantle cell lymphomas. Mod Pathol 2002; 15: 517–525
   PubMed Web of Science ®Google Scholar
• Rosenwald A, Wright G, Wiestner A, Chan W C, Connors J M, Campo E, et al. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell 2003; 3: 185–197
   PubMed Web of Science ®Google Scholar
• Stilgenbauer S, Liebisch P, James M R, Schroder M, Schlegelberger B, Fischer K, et al. Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11q22.3-923.1 in lymphoproliferative disorders. Proc Natl Acad Sci USA 1996; 93: 11837–11841
   PubMed Web of Science ®Google Scholar
• Monni O, Zhu Y, Franssila K, Oinonen R, Hoglund P, Elonen E, et al. Molecular characterization of deletion at 11q22.1-23.3 in mantle cell lymphoma. Br J Haematol 1999; 104: 665–671
   PubMed Web of Science ®Google Scholar
• Stilgenbauer S, Winkler D, Ott G, Schaffner C, Leupolt E, Bentz M, et al. Molecular characterization of 11q deletions points to a pathogenic role of the ATM gene in mantle cell lymphoma. Blood 1999; 94: 3262–3264
   PubMed Web of Science ®Google Scholar
• Cuneo A, Bigoni R, Rigolin G M, Roberti M G, Milani R, Bardi A, et al. Acquired chromosome 11q deletion involving the ataxia teleangiectasia locus in B-cell non-Hodgkin's lymphoma: correlation with clinicobiologic features. J Clin Oncol 2000; 18: 2607–2614
   PubMed Web of Science ®Google Scholar
• Schaffner C, Idler I, Stilgenbauer S, Dohner H, Lichter P. Mantle cell lymphoma is characterized by inactivation of the ATM gene. Proc Natl Acad Sci USA 2000; 97: 2773–2778
   PubMed Web of Science ®Google Scholar
• Decaudin D. Mantle cell lymphoma: a biological and therapeutic paradigm. Leuk Lymphoma 2002; 43: 773–781
   PubMed Web of Science ®Google Scholar
• Swerdlow S H, Williams M E. From centrocytic to mantle cell lymphoma: a clinicopathologic and molecular review of 3 decades. Hum Pathol 2002; 33: 7–20
   PubMed Web of Science ®Google Scholar
• Camacho E, Hernandez L, Hernandez S, Tort F, Bellosillo B, Bea S, et al. ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances. Blood 2002; 99: 238–244
   PubMed Web of Science ®Google Scholar
• Greiner T C, Moynihan M J, Chan W C, Lytle D M, Pedersen A, Anderson J R, et al. p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis. Blood 1996; 87: 4302–4310
   PubMed Web of Science ®Google Scholar
• Weisenburger D D, Vose J M, Greiner T C, Lynch J C, Chan W C, Bierman P J, et al. Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group. Am J Hematol 2000; 64: 190–196
   PubMed Web of Science ®Google Scholar
• Dreyling M H, Bullinger L, Ott G, Stilgenbauer S, Muller-Hermelink H K, Bentz M, et al. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma. Cancer Res 1997; 57: 4608–4614
   PubMed Web of Science ®Google Scholar
• Pinyol M, Hernandez L, Cazorla M, Balbin M, Jares P, Fernandez P L, et al. Deletions and loss of expression of p16INK4a and p21Waf1 genes are associated with aggressive variants of mantle cell lymphomas. Blood 1997; 89: 272–280
   PubMed Web of Science ®Google Scholar
• Hernandez L, Bea S, Pinyol M, Ott G, Katzenberger T, Rosenwald A, et al. CDK4 and MDM2 gene alterations mainly occur in highly proliferative and aggressive mantle cell lymphomas with wild-type INK4a/ARF locus. Cancer Res 2005; 65: 2199–2206
   PubMed Web of Science ®Google Scholar
• Au W Y, Horsman D E, Viswanatha D S, Connors J M, Klasa R J, Gascoyne R D. 8q24 translocations in blastic transformation of mantle cell lymphoma. Haematologica 2000; 85: 1225–1227
   PubMed Web of Science ®Google Scholar
• Nagy B, Lundan T, Larramendy M L, Aalto Y, Zhu Y, Niini T, et al. Abnormal expression of apoptosis-related genes in haematological malignancies: overexpression of MYC is poor prognostic sign in mantle cell lymphoma. Br J Haematol 2003; 120: 434–441
   PubMed Web of Science ®Google Scholar
• Au W Y, Horsman D E, Gascoyne R D, Viswanatha D S, Klasa R J, Connors J M. The spectrum of lymphoma with 8q24 aberrations: a clinical, pathological and cytogenetic study of 87 consecutive cases. Leuk Lymphoma 2004; 45: 519–528
   PubMed Web of Science ®Google Scholar
• Michaux L, Wlodarska I, Theate I, Stul M, Scheiff J M, Deneys V, et al. Coexistence of BCL1/CCND1 and CMYC aberrations in blastoid mantle cell lymphoma: a rare finding associated with very poor outcome. Ann Hematol 2004; 83: 578–583
   PubMed Web of Science ®Google Scholar
• Sander B, Islam T, Kimby E, Smith C IE, Christensson B. American Society of Hematology abstracts. Blood 2002, abstract no. 4676
   PubMed Web of Science ®Google Scholar
• Islam T C, Asplund A C, Lindvall J M, Nygren L, Liden J, Kimby E, et al. High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphoma. Leukemia 2003; 17: 1880–1890
   PubMed Web of Science ®Google Scholar
• Sander B, Flygare J, Porwit-Macdonald A, Smith C I, Emanuelsson E, Kimby E, et al. Mantle cell lymphomas with low levels of cyclin D1 long mRNA transcripts are highly proliferative and can be discriminated by elevated cyclin A2 and cyclin B1. Int J Cancer 2005; 117: 418–430
   PubMed Web of Science ®Google Scholar
• Raty R, Franssila K, Joensuu H, Teerenhovi L, Elonen E. Ki-67 expression level, histological subtype, and the International Prognostic Index as outcome predictors in mantle cell lymphoma. Eur J Haematol 2002; 69: 11–20
   PubMed Web of Science ®Google Scholar
• Ek S, Bjorck E, Porwit-MacDonald A, Nordenskjold M, Borrebaeck C A. Increased expression of Ki-67 in mantle cell lymphoma is associated with de-regulation of several cell cycle regulatory components, as identified by global gene expression analysis. Haematologica 2004; 89: 686–695
   PubMed Web of Science ®Google Scholar
• Tiemann M, Schrader C, Klapper W, Dreyling M H, Campo E, Norton A, et al. Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network. Br J Haematol 2005; 131: 29–38
   PubMed Web of Science ®Google Scholar
• Monni O, Oinonen R, Elonen E, Franssila K, Teerenhovi L, Joensuu H, et al. Gain of 3q and deletion of 11q22 are frequent aberrations in mantle cell lymphoma. Genes Chromosomes Cancer 1998; 21: 298–307
   PubMed Web of Science ®Google Scholar
• Bea S, Ribas M, Hernandez J M, Bosch F, Pinyol M, Hernandez L, et al. Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants. Blood 1999; 93: 4365–4374
   PubMed Web of Science ®Google Scholar
• Bentz M, Plesch A, Bullinger L, Stilgenbauer S, Ott G, Muller-Hermelink H K, et al. t(11;14)-positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemia. Genes Chromosomes Cancer 2000; 27: 285–294
   PubMed Web of Science ®Google Scholar
• Monni O, Knuutila S. 11q deletions in hematological malignancies. Leuk Lymphoma 2001; 40: 259–266
   PubMed Web of Science ®Google Scholar
• Greiner T C, Dasgupta C, Ho V V, Weisenburger D D, Smith L M, Lynch J C, et al. Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma. Proc Natl Acad Sci USA 2006; 103: 2352–2357
   PubMed Web of Science ®Google Scholar
• Hernandez L, Fest T, Cazorla M, Teruya-Feldstein J, Bosch F, Peinado M A, et al. p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas. Blood 1996; 87: 3351–3359
   PubMed Web of Science ®Google Scholar
• Cuneo A, Bigoni R, Rigolin G M, Roberti M G, Bardi A, Piva N, et al. Cytogenetic profile of lymphoma of follicle mantle lineage: correlation with clinicobiologic features. Blood 1999; 93: 1372–1380
   PubMed Web of Science ®Google Scholar
• Bigoni R, Cuneo A, Milani R, Roberti M G, Bardi A, Rigolin G M, et al. Secondary chromosome changes in mantle cell lymphoma: cytogenetic and fluorescence in situ hybridization studies. Leuk Lymphoma 2001; 40: 581–590
   PubMed Web of Science ®Google Scholar
• Solenthaler M, Matutes E, Brito-Babapulle V, Morilla R, Catovsky D. p53 and mdm2 in mantle cell lymphoma in leukemic phase. Haematologica 2002; 87: 1141–1150
   PubMed Web of Science ®Google Scholar
• Sharpless N E. INK4a/ARF: a multifunctional tumor suppressor locus. Mutat Res 2005; 576: 22–38
   PubMed Web of Science ®Google Scholar
• Hutter G, Scheubner M, Zimmermann Y, Kalla J, Katzenberger T, Hubler K, et al. Differential effect of epigenetic alterations and genomic deletions of CDK inhibitors [p16(INK4a), p15(INK4b), p14(ARF)] in mantle cell lymphoma. Genes Chromosomes Cancer 2006; 45: 203–210
   Web of Science ®Google Scholar
• Tirier C, Zhang Y, Plendl H, Weber-Matthiesen K, Langer W, Heit W, et al. Simultaneous presence of t(11;14) and a variant Burkitt's translocation in the terminal phase of a mantle cell lymphoma. Leukemia 1996; 10: 346–350
   PubMed Web of Science ®Google Scholar
• Vaishampayan U N, Mohamed A N, Dugan M C, Bloom R E, Palutke M. Blastic mantle cell lymphoma associated with Burkitt-type translocation and hypodiploidy. Br J Haematol 2001; 115: 66–68
   PubMed Web of Science ®Google Scholar
• Hao S, Sanger W, Onciu M, Lai R, Schlette E J, Medeiros L J. Mantle cell lymphoma with 8q24 chromosomal abnormalities: a report of 5 cases with blastoid features. Mod Pathol 2002; 15: 1266–1272
   PubMed Web of Science ®Google Scholar
• Thelander E F, Walsh S H, Thorselius M, Laurell A, Landgren O, Larsson C, et al. Mantle cell lymphomas with clonal immunoglobulin V(H)3-21 gene rearrangements exhibit fewer genomic imbalances than mantle cell lymphomas utilizing other immunoglobulin V(H) genes. Mod Pathol 2005; 18: 331–339
   PubMed Web of Science ®Google Scholar
• Martinez-Climent J A, Vizcarra E, Sanchez D, Blesa D, Marugan I, Benet I, et al. Loss of a novel tumor suppressor gene locus at chromosome 8p is associated with leukemic mantle cell lymphoma. Blood 2001; 98: 3479–3482
   PubMed Web of Science ®Google Scholar
• Vizcarra E, Martinez-Climent J A, Benet I, Marugan I, Terol M J, Prosper F, et al. Identification of two subgroups of mantle cell leukemia with distinct clinical and biological features. Hematol J 2001; 2: 234–2341
   PubMedGoogle Scholar
• Rubio-Moscardo F, Climent J, Siebert R, Piris M A, Martin-Subero J I, Nielander I, et al. Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome. Blood 2005; 105: 4445–4454
   PubMed Web of Science ®Google Scholar